Buradasınız

Ağır Proliferatif Karakterdeki Diyabetik Retinopatili Olgularda intravitreal Bevacizumab Enjeksiyonunu Takiben Bimanuel Teknikle Pars Plana Vitnektomi

Pars plana vitrectomy using bimanual technique following intravitreal bevacizumab injection for patients suffering severe proliferative diabetic retinopathy

Journal Name:

Publication Year:

Abstract (2. Language): 
Objectives: To evaluate the anatomic and functional results of pars plana vitrectomy performed with bimanual technique following intravitreal bevacizumab injection in florid type severe PDR patients with intense neovascular vessel and membrane formation. Methods: 14 eyes of 10 patients, in a group of 7 females and 3 males whose ages ranged from 23 and 54, presenting intense neovascular vessel and membrane formation with various degrees of intravitreal haemorrhage were studied. 1.25 mg of 0.05mL bevacizumab injections were performed 3-7 days before surgery. 6 of the 12 phakic eyes were performed fakoemulsification and IOL implantation in the bag just before the surgery. PPV was performed using three-port vitrectomy approach and membranes were peeled with the help of a twinlight chandelier by the bimanual technique. Following aggressive endophotocoagulation, intraocular tampon was inserted (5 eyes C3F8 / 9 eyes silicone oil). Patients were followed up for at least 3 months. Results: 7 patients had preoperative visual acuity of hand movement, 4 patients had a visual acuity of finger counting from 1 meter, 1 patient had a visual acuity of finger counting from 3 meters and 2 patients had a visual acuity of 1/10 respectively. 10 of the patients had a visual acuity measured 5/200 or better after the surgery. (Patients with a pre-operative visual acuity of hand movement were 3/7, and patients with a better visual acuity were 7/7). Anatomic success was achieved in all cases. The cause of failure in patients whom visual acuity did not improve after surgery was attributed to optic atrophy and unfunctionality of large vessels. One of the patients suffered from aggressive rubeosis iridis and neovascular glaucoma postoperatively. Conclusion: Satisfactory anatomic and functional results can be achieved by using bimanual technique and inhibiting neovascularisation in severe PDR patients, whom surgery was avoided and accepted as unsuccessful in recent years because of heavy bleeding and retinal tears.
Abstract (Original Language): 
Amaç: Yoğun neovasküler damar ve membranları bulunan florid karakterdeki ağır proliferatif diyabetik retinopatili olgularında intravitreal bevacizumab enjeksiyonunu takiben bimanuel teknikle yapılan pars plana vitrektomi cerrahisinin anatomik ve fonksiyonel sonuçlarını irdelemek. Yöntem: Yaşları 23 ile 54 arasında değişen, yoğun neovasküler damarlar ve membranlar yanında değişik miktarlarda VİH gösteren, 7’si kadın, 3’ü erkek 10 diyabetli olgunun 14 gözü çalışmaya alındı. Olgulara cerrahiden 3-7 gün önce 1.25 mg 0.05 ml intravitreal bevacizumab enjeksiyonu uygulandı. Fakik 12 gözden 6’sına cerrahinin başında fakoemülsifikasyon ve in the bag GIL uygulandı. 3’lü giriflimle PPV yapı- lıp; membranlar bir twinlight chandelier varlığında bimanuel teknikle soyuldu. Agresif endofotokoagülasyonu takiben bir göz içi tamponu yerleştirildi (5 göz C3F8 / 9 göz silikon yağı). Olgular en az 3 ay takip edildi. Bulgular: Cerrahi öncesi gözlerden 7‘si EH, 4‘ü 1 mps, biri 3 mps ve ikisi 1/10 görme keskinliğine sahipti. Cerrahi sonrasında gözlerden 10’u 5/200 ya da daha iyi bir görme seviyesine sahip oldu (Başlangıçta görme seviyesi EH olan gözlerde 3/7, EH’den daha iyi olan gözlerde 7/7). Tüm olgularda anatomik başarı sağlandı. Görme seviyesi artmayan olgularda başlıca neden optik atrofi ve büyük damarların fonksiyon göremez durumda oluşuydu. 1 olguda ise cerrahiden bir süre sonra agresif bir rubeozis ve neovasküler glokom gelişti. Sonuç: Daha önceki yıllarda ağır kanamalar ve retina yırtıkları nedeniyle başarısız olduğumuz ve cerrahi uygulamaktan kaçındığımız pek çok ileri PDR’li olguda neovaskülarizasyonun baskılanması ve bimanuel tetkik sayesinde tatminkar anatomik ve fonksiyonel sonuçlara ulaşılabilmektedir.
72-76

REFERENCES

References: 

Kaynaklar
1. Favard C, Guyot-Argenton C, Assouline M, et al. Full
panretinal photocoagulation and early vitrectomy
improve prognosis of florid diabetic retinopathy.
Ophthalmology 1996; 103: 561-574.
2. Lattanzio R, Brancato R, Bandello FM, et al. Florid diabetic
retinopathy (FDR): a long-term follow-up study.
Graefes Arch Clin Exp Ophthalmol 2001; 239: 182-187.
3. Lee MS, Abrams GW. Membrane dissection in proliferative
diabetic retinopathy. In: Peyman GA, Meffert SA,
Conway MD, Chou F, eds. Vitreoretinal Surgical
Techniques. London: Martin Dunitz; 2001. p. 251-266.
4. Eliott D, Lee MS, Abrams GW. Proliferative diabetic
retinopathy: Principles and techniques of surgical
treatment. In: Ryan SJ, Wilkinson CP, eds. Retina.
China: Elsevier Mosby; 2006. pp. 2413-2449.
5. Avc› R. Proliferatif Diabetik Retinopatide Vitreoretinal
Cerrahi. Retina “Güncel Tan› ve Tedavi”. 28. Ulusal
Oftalmoloji Kurs Kitab›. Ankara, 2008: 277-287.
6. Karaçorlu M, Özdemir H, Karaçorlu S, Alacal› N.
Regression of optic nerve head novascularization in
proliferative diabetic retinopathy after intravitreal triamcinolone.
International Ophthalmol 2004; 25: 113-116.
7. Bandello F, Pognuz DR, Piracchio A, Polito A.
Intravitreal triamcilone acetonide for florid proliferative
diabetic retinopathy. Graefe’s Arch Clin Exp
Ophthalmol 2004; 242: 1024-1027.
8. Spaide RF, Fisher YL. Intravitreal bevacizumab
(Avastin) treatment of proliferative diabetic retinopathy
complicated by vitreous hemorrhage. Retina 2006; 26:
275-278.
9. Avery RL, Pearlman J, Pieramici DJ, et al. Intravitreal
bevacizumab (Avastin) in the treatment of proliferative
diabetic retinopathy. Ophthalmology 2006; 113:
1695-1705.
76
M. Yolar ve ark.
10. Öncel M. Panretinal photocoagulation combined with
bevacizumab for proliferative diabetic retinopathy.
AAO Nov. 9-10, 2007 Retina Subspeciality Day 2007;
166-167.
11. Ishikawa K, Honda S, Tsukahara Y, Negi A. Preferable
use of intravitreal bevacizumab as a pretreatment of
vitrectomy for severe proliferative diabetic retinopathy.
Eye 2009; 23: 108-111.
12. Chen E, Park CH. Use of intravitreal bevacizumab as a
proliferative adjunct for tractional retinal detachment
repair in severe proliferative diabetic retinopathy.
Retina 2006; 26: 699-700.
13. Rizzo S, Genovesi-Ebert F, Di Bartolo E, et al. Injection
of intravitreal bevacizumab (Avastin) as a preoperative
adjunct before vitrectomy surgery in the treatment of
severe proliferative diabetic retinopathy (PDR).
Graefes Arch Clin Exp Ophthalmol 2008; 246: 837-
842.
14. Oshima Y, Shima C, Wakabayashi S, et al.
Microinsizyon vitrectomi surgery and intravitreal
bevacizumab as a surgical adjunct to treat diabetic
traction retinal detachment. Ophthalmol 2009; 116:
927-938.

Thank you for copying data from http://www.arastirmax.com